Clinical Trial Update: TB-IRIS NSAID Cox-2 Inhibitor Prevention Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether a COX-2 selective NSAID can prevent TB-IRIS in individuals with tuberculosis. The sponsor is the University of Stellenbosch, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• COX-2 selective NSAID (cyclooxygenase-2 inhibitor)

Snippet

Sponsor: University of Stellenbosch | Conditions: Tuberculosis | Phase 3 | Status: UNKNOWN